1
|
Chan E, Sammaraiee Y, Banerjee G, Martin AF, Farmer S, Cowley P, Sayal P, Kharytaniuk N, Eleftheriou P, Porter J, van Harskamp N, Cipolotti L, Werring DJ. Neuropsychological and neuroimaging characteristics of classical superficial siderosis. J Neurol 2021; 268:4238-4247. [PMID: 33866413 DOI: 10.1007/s00415-021-10548-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Accepted: 04/05/2021] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To define the neuropsychological and neuroimaging characteristics of classical infratentorial superficial siderosis (iSS), a rare but disabling disorder defined by hemosiderin deposition affecting the superficial layers of the cerebellum, brainstem and spinal cord, usually associated with a slowly progressive neurological syndrome of deafness, ataxia and myelopathy. METHODS We present the detailed neuropsychological and neuroimaging findings in 16 patients with iSS (mean age 57 years; 6 female). RESULTS Cognitive impairment was present in 8/16 (50%) of patients: executive dysfunction was the most prevalent (44%), followed by impairment of visual recognition memory (27%); other cognitive domains were largely spared. Disease symptom duration was significantly correlated with the number of cognitive domains impaired (r = 0.59, p = 0.011). Mood disorders were also common (anxiety 62%, depression 38%, both 69%) but not associated with disease symptom duration. MRI findings revealed siderosis was not only in infratentorial brain regions, but also in characteristic widespread symmetrical supratentorial brain regions, independent of disease duration and degree of cognitive impairment. The presence of small vessel disease markers was very low and did not account for the cognitive impairment observed. CONCLUSION Neuropsychological disturbances are common in iSS and need to be routinely investigated. The lack of association between the anatomical extent of hemosiderin and cognitive impairment or disease duration suggests that hemosiderin itself is not directly neurotoxic. Additional biomarkers of iSS disease severity and progression are needed for future research and clinical trials.
Collapse
Affiliation(s)
- Edgar Chan
- Department of Neuropsychology, National Hospital for Neurology and Neurosurgery, Queen Square, Box 37, London, WC1N 3BG, UK. .,Department of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Russell Square House, London, UK.
| | - Yezen Sammaraiee
- Department of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Russell Square House, London, UK
| | - Gargi Banerjee
- Department of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Russell Square House, London, UK
| | - Andreas Flores Martin
- Department of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Russell Square House, London, UK
| | - Simon Farmer
- National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
| | - Peter Cowley
- National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
| | - Parag Sayal
- National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
| | - Natallia Kharytaniuk
- Department of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Russell Square House, London, UK
| | | | - John Porter
- Department of Haematology, University College London, London, UK
| | - Natasja van Harskamp
- Department of Neuropsychology, National Hospital for Neurology and Neurosurgery, Queen Square, Box 37, London, WC1N 3BG, UK
| | - Lisa Cipolotti
- Department of Neuropsychology, National Hospital for Neurology and Neurosurgery, Queen Square, Box 37, London, WC1N 3BG, UK.,Department of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Russell Square House, London, UK
| | - David J Werring
- Department of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Russell Square House, London, UK
| |
Collapse
|
2
|
Yoo A, Jou J, Klopfenstein JD, Kattah JC. Focused Neuro-Otological Review of Superficial Siderosis of the Central Nervous System. Front Neurol 2018; 9:358. [PMID: 29892257 PMCID: PMC5985612 DOI: 10.3389/fneur.2018.00358] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2017] [Accepted: 05/02/2018] [Indexed: 12/27/2022] Open
Abstract
Background Infratentorial siderosis (iSS) is a progressive degenerative disorder targeting primarily the cerebellum and cranial nerve eighth; therefore, progressive ataxia and its neuro-otological findings are common. Toxicity from hemosiderin involves selectively vulnerable neurons and glia in these posterior fossa structures. Other neurologic findings may be present, though our focus relates to the cochlea-vestibular cerebellar involvement. Radiographic evidence of siderosis may be the result of recurrent, albeit covert bleeding in the subarachnoid space, or the consequence of an overt post-traumatic or aneurysmal subarachnoid hemorrhage (SAH). The radiographic iSS appearance is identical regardless of the SAH cause. A recent study provides compelling evidence to search and correct possible hemorrhage sources in the spinal canal. The removal of residual existing hemosiderin deposits that may potentially cause clinical symptoms remains as a major therapeutic challenge. Methods We reviewed large data sources and identified salient papers that describe the pathogenesis, clinical and neurotologic manifestations, and the radiographic features of iSS. Results The epidemiology of iSS is unknown. In a recent series, clinically evident iSS was associated with recurrent SAH; by contrast, in a follow-up period ranging from weeks up to 11 years after a monophasic episode of SAH, radiographic siderosis was clinically silent. However, the post-aneurysmal or post-trauma SAH sample size in this single study was small and their observation period relatively short; moreover, the burden of intraneuronal hemosiderin is likely greater with recurrent SAH. There are a few reports of late iSS, several decades after traumatic SAH. A recent report found subjective hearing loss in aneurysmal SAH individuals with radiographic siderosis. Only in recent years, it is safe to perform magnetic resonance imaging (MRI) in post-aneurysmal SAH, because of the introduction of titanium, MRI-compatible aneurysm clips. Conclusion iSS can be associated with significant neurotologic and cerebellar morbidity; the recurrent SAH variant is frequently clinically symptomatic, has a shorter latency and greater neurotologic disability. In these cases, a thorough search and management of a covert source of bleeding may stop clinical progression. The frequency and clinical course of radiographic iSS after traumatic and post-aneurysmal SAH is largely unknown. Detection of radiographic iSS after trauma or aneurysm bleeding suggests that the slower clinical course could benefit from an effective intervention if it became available. The use of cochlear implants is a valid alternative with advanced hearing impairment.
Collapse
Affiliation(s)
- Aran Yoo
- University of Illinois College of Medicine, Peoria, IL, United States
| | - Jonathan Jou
- University of Illinois College of Medicine, Peoria, IL, United States
| | - Jeffrey D Klopfenstein
- Department of Neurosurgery, University of Illinois College of Medicine, Peoria, IL, United States
| | - Jorge C Kattah
- Department of Neurology, Illinois Neurologic Institute, University of Illinois College of Medicine, Peoria, IL, United States
| |
Collapse
|